Immune modulation during infection by a secreted fungal polysaccharide
分泌的真菌多糖在感染过程中的免疫调节
基本信息
- 批准号:10447591
- 负责人:
- 金额:$ 38.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-24 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAlveolar MacrophagesAttenuatedBiogenesisBloodBrainCell physiologyCell surfaceCellsCentral Nervous System InfectionsCerebrospinal FluidCessation of lifeClinicalCryptococcosisCryptococcusCryptococcus neoformansDataDiseaseDistalDrug TargetingEnvironmentFungal MeningitisFungal SporesFutureGenerationsGeneticGrowthHealth Care CostsHealthcare SystemsImmuneImmune mediated destructionImmune responseImmune systemImmunocompromised HostImmunosuppressive AgentsInfectionInfiltrationLeukocytesLungMeningitisModelingMolecularMusMycosesOrganPathogenesisPathway interactionsPatientsPhagocytosisPharmaceutical PreparationsPlayPolymersPolysaccharidesProcessProductionPropertyPublic HealthRegulationRoleSerumSiteStarvationSurfaceTestingTherapeutic immunosuppressionTissuesTreatment Side EffectsVirulenceVirulence FactorsWorkalveolar destructioncapsuleexperimental studyfungusglucuronoxylomannanimmunoregulationmonocytemutantpathogenpathogenic funguspreventresponsetool
项目摘要
Systemic fungal infections are a major public health concern, annually causing over 1.3 million deaths
worldwide and costing healthcare systems billions of dollars. These infections are difficult and expensive to
treat due to a limited number of drugs and poor understanding of infectious mechanisms.
Cryptococcus neoformans is the major cause of fungal meningitis, annually responsible for
approximately 1 million infections and 600,000 deaths worldwide. The majority of these cases are in HIV/AIDS
patients. Infections begin in the lungs but in severe cases spread to the brain, causing a difficult-to-treat
meningitis infection. C. neoformans produces a large cell surface capsule, the predominant component of
which is the polysaccharide glucuronoxylomannan (GXM). GXM is necessary for infection, facilitates C.
neoformans's ability to evade phagocytosis and destruction by immune cells, and inhibits immune responses.
In addition to cell surface GXM, free secreted GXM (exo-GXM) has been long thought to play a role in
infection. Free GXM circulates in serum and cerebrospinal fluid during and after infection. However, its precise
role and biogenesis are not understood. We have identified the first mutants in this secretion pathway and will
determine how secreted GXM facilitates infection and dissemination of C. neoformans.
We find that GXM accumulates in the tissue of infected mice before C. neoformans cells spread from
the lungs to those tissues, suggesting that exo-GXM facilitates dissemination. First, we will separate different
steps of dissemination and determine how exo-GXM contributes to each. Second, we will determine how exo-
GXM inhibits the immune response during infection by testing two hypotheses: 1) exo-GXM blocks immune cell
infiltration into tissue and 2) exo-GXM prevents maturation or differentiation of circulating leukocytes. Finally,
we will determine the molecular mechanisms of exo-GXM generation and regulation. These experiments will
separate exo-GXM function from cell surface GXM function, determine how exo-GXM modulates the
mammalian immune system during infection, and help determine whether exo-GXM could be developed as an
immunosuppressive drug.
系统性真菌感染是一个主要的公共卫生问题,每年导致130多万人死亡
在全球范围内,并花费医疗保健系统数十亿美元。这些感染是困难和昂贵的
由于药物数量有限和对感染机制了解不足而导致的治疗。
新生隐球菌是引起真菌性脑膜炎的主要原因,每年
全球约有100万人感染,60万人死亡。这些病例大多数是艾滋病毒/艾滋病。
病人。感染开始于肺部,但在严重的情况下会扩散到大脑,导致难以治疗的
脑膜炎感染。新生革兰氏杆菌产生一个大的细胞表面被膜,这是
即葡糖醛酸木甘露聚糖(GXM)。GXM是感染所必需的,促进C。
新生杆菌能够逃避免疫细胞的吞噬和破坏,并抑制免疫反应。
除了细胞表面的GXM,自由分泌的GXM(exo-GXM)长期以来一直被认为在
感染。在感染期间和感染后,血清和脑脊液中有游离的GXM循环。然而,它的精确度
角色和生物发生还不清楚。我们已经在这个分泌途径中发现了第一个突变体,并将
确定分泌的GXM如何促进新生葡萄球菌的感染和传播。
我们发现GXM在感染小鼠的组织中蓄积,然后新生葡萄球菌细胞从
肺到这些组织,这表明外源GXM有助于扩散。首先,我们将分开不同的
传播步骤,并确定外源GXM对每个步骤的贡献。其次,我们将确定外部环境如何-
GXM通过检验两个假设来抑制感染过程中的免疫反应:1)外源性GXM阻断免疫细胞
渗入组织和2)外源性GXM阻止循环中白细胞的成熟或分化。最后,
我们将确定外源GXM的产生和调控的分子机制。这些实验将
将exo-GXM函数从细胞表面GXM函数中分离出来,确定exo-GXM如何调制
哺乳动物在感染过程中的免疫系统,并帮助确定外源GXM是否可以发展为
免疫抑制药。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A dissemination-prone morphotype enhances extrapulmonary organ entry by Cryptococcus neoformans.
- DOI:10.1016/j.chom.2022.08.017
- 发表时间:2022-10-12
- 期刊:
- 影响因子:30.3
- 作者:Denham, Steven T.;Brammer, Brianna;Chung, Krystal Y.;Wambaugh, Morgan A.;Bednarek, Joseph M.;Guo, Li;Moreau, Christian T.;Brown, Jessica C. S.
- 通讯作者:Brown, Jessica C. S.
Biology and function of exo-polysaccharides from human fungal pathogens.
- DOI:10.1007/s40588-020-00137-5
- 发表时间:2020-03
- 期刊:
- 影响因子:5.2
- 作者:Chung KY;Brown JCS
- 通讯作者:Brown JCS
Distinct pathways of adaptive evolution in Cryptococcus neoformans reveal a mutation in adenylyl cyclase with trade-offs for pathogenicity.
- DOI:10.1016/j.cub.2023.08.054
- 发表时间:2023-10-09
- 期刊:
- 影响因子:9.2
- 作者:Hilbert, Zoe A.;Bednarek, Joseph M.;Schwiesow, Mara J. W.;Chung, Krystal Y.;Moreau, Christian T.;Brown, Jessica C. S.;Elde, Nels C.
- 通讯作者:Elde, Nels C.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JESSICA Conrad BROWN其他文献
JESSICA Conrad BROWN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JESSICA Conrad BROWN', 18)}}的其他基金
Exploiting synergistic and antagonistic interactions with antifungal drugs to improve disease treatment.
利用与抗真菌药物的协同和拮抗相互作用来改善疾病治疗。
- 批准号:
10204979 - 财政年份:2019
- 资助金额:
$ 38.13万 - 项目类别:
Exploiting synergistic and antagonistic interactions with antifungal drugs to improve disease treatment.
利用与抗真菌药物的协同和拮抗相互作用来改善疾病治疗。
- 批准号:
10456329 - 财政年份:2019
- 资助金额:
$ 38.13万 - 项目类别:
Immune modulation during infection by a secreted fungal polysaccharide
分泌的真菌多糖在感染过程中的免疫调节
- 批准号:
10180886 - 财政年份:2018
- 资助金额:
$ 38.13万 - 项目类别:
相似海外基金
The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
- 批准号:
23K08315 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
MICA: Key mechanisms underlying inhaled GM-CSF's enhancement of phagocytosis and bacterial clearance by human alveolar macrophages.
MICA:吸入 GM-CSF 增强人肺泡巨噬细胞吞噬作用和细菌清除的关键机制。
- 批准号:
MR/X005046/1 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Research Grant
Analysis of pathogenic alveolar macrophages which release IL-1alpha in response to fine particles.
分析响应细颗粒物释放 IL-1α 的致病性肺泡巨噬细胞。
- 批准号:
23H03154 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Glutamine Metabolism in Alveolar Macrophages following Influenza A Infection
甲型流感感染后肺泡巨噬细胞的谷氨酰胺代谢
- 批准号:
10607319 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
The function and regulation of tissue resident alveolar macrophages turnover by host and environmental factors during homeostasis and in infections
稳态和感染期间宿主和环境因素对组织驻留肺泡巨噬细胞周转的功能和调节
- 批准号:
471247 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Fellowship Programs
Using a Lung on Chip Device to Study Alveolar Macrophages as Intracellular Reservoirs for Staphylococcus aureus
使用肺芯片装置研究肺泡巨噬细胞作为金黄色葡萄球菌的细胞内储库
- 批准号:
485971 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Studentship Programs
Analysis of innate immune response of alveolar macrophages and epithelial-mesenchymal transition of alveolar epithelial cells
肺泡巨噬细胞的先天免疫反应和肺泡上皮细胞的上皮间质转化分析
- 批准号:
22K06698 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cholesterol crystal-mediated inflammation in alveolar macrophages: an emerging role inidiopathic lung fibrosis?
胆固醇晶体介导的肺泡巨噬细胞炎症:在特发性肺纤维化中的新兴作用?
- 批准号:
462596862 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
WBP Position
Elucidation of idiopathic pneumonia syndrome: Angiotensin 2 activates alveolar macrophages
特发性肺炎综合征的阐明:血管紧张素 2 激活肺泡巨噬细胞
- 批准号:
21K16251 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Establishment of novel macrophage cell lines to study the pathogenesis of respiratory bacterial pathogens in lung alveolar macrophages
建立新型巨噬细胞系以研究肺泡巨噬细胞中呼吸道细菌病原体的发病机制
- 批准号:
NC/V001019/1 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
Research Grant














{{item.name}}会员




